Lexeo Therapeutics News

Lexeo Therapeutics | 8-K: Lexeo Therapeutics Reports Second Quarter 2024 Financial Results and Operational Highlights

Aug 12 19:05

Lexeo Therapeutics | 8-K: Current report

Jul 15 19:59

Lexeo Therapeutics | 8-K: Current report

Jul 8 19:02

Lexeo Therapeutics | 8-K: Current report

Jun 28 19:36

Lexeo Therapeutics | 8-K: Lexeo Therapeutics Reports First Quarter 2024 Financial Results and Operational Highlights

May 9 19:12

Lexeo Therapeutics | DEFA14A: Others

Apr 26 19:58

Lexeo Therapeutics | DEF 14A: Definitive information statements

Apr 26 19:58

Lexeo Therapeutics | 8-K: Current report

Apr 22 20:25

Lexeo Therapeutics | 8-K: Current report

Apr 22 20:15

Lexeo Therapeutics | 8-K: Current report

Apr 16 19:35

Lexeo Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Apr 9 20:04

Lexeo Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 12 04:15

Lexeo Therapeutics | 8-K: Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Mar 12 04:13

Lexeo Therapeutics | 8-K: Current report

Feb 5 20:07

Lexeo Therapeutics | 8-K: Current report

Dec 18, 2023 20:00

Lexeo Therapeutics | 8-K: Lexeo Therapeutics Reports Third Quarter 2023 Financial Results and Operational Highlights

Dec 11, 2023 20:03

Lexeo Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 8, 2023 06:13

Lexeo Therapeutics | 8-K: Current report

Nov 8, 2023 05:10

Lexeo Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Nov 2, 2023 04:59

Lexeo Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Oct 30, 2023 18:43